Cardio-TriTest vs cV4 Diagnostic Ultrasound System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Cardio-TriTest

by Cardio-Phoenix Inc.

cV4 Diagnostic Ultrasound System

by Samsung Medison Co.

AI Verdict

Cardio-TriTest is a specialized device for comprehensive cardiovascular disease detection using a combination of ECG, PCG, and MCG bio-signals. In contrast, the cV4 Diagnostic Ultrasound System is a versatile ultrasound platform with AI features primarily focused on advanced imaging and automated assessments across multiple specialties, including fetal heart analysis. While both leverage AI for cardiac-related diagnostics, they employ different modalities and target distinct clinical applications, making them suitable for different needs.

Choose Cardio-TriTest if…

Choose Cardio-TriTest if your primary objective is early and comprehensive cardiovascular disease detection within a primary care or general cardiology setting. This AI-powered device uniquely combines and visually correlates ECG, PCG, and MCG bio-signals to offer a more thorough initial assessment of heart health.

View Cardio-TriTest →

Choose cV4 Diagnostic Ultrasound System if…

Choose the Samsung Medison cV4 Diagnostic Ultrasound System if your clinical practice requires advanced AI-enabled ultrasound imaging for diverse applications, especially in maternal-fetal medicine, obstetrics, gynecology, or radiology. Its specialized AI features, such as HeartAssist, BiometryAssist, and NerveTrack, provide enhanced diagnostic confidence for fetal assessment and real-time nerve detection.

View cV4 Diagnostic Ultrasound System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Cardio-TriTest	cV4 Diagnostic Ultrasound System
Pricing	Contact for pricing	Contact for pricing
Deployment	Clinical setting (device-based)	On-premise (physical hardware device)
FDA Status	Cleared AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

cV4 Diagnostic Ultrasound System

Tool B, the cV4 Diagnostic Ultrasound System, explicitly highlights 'streamlined workflows' and integrates multiple AI-powered assists (HeartAssist, NerveTrack, BiometryAssist, LaborAssist) designed to automate tasks and improve operator efficiency. Its fanless design also contributes to a quieter and more comfortable user environment. While Tool A offers a non-invasive 3-in-1 test, Tool B's specific features directly address operational usability and workflow enhancement.

Clinical Value

cV4 Diagnostic Ultrasound System

Tool B offers 'advanced imaging' through its Crystal Architectureu2122 (CrystalBeamu2122 & CrystalLiveu2122) for enhanced image quality, which is fundamental to diagnostic confidence in ultrasound. It also provides multiple AI-powered assists for automated assessments across diverse specialties like maternal-fetal medicine and radiology, directly contributing to diagnostic accuracy and efficiency. While Tool A provides comprehensive cardiovascular detection, Tool B's combination of advanced imaging and specific AI-driven automation across multiple applications offers a broader and highly impactful clinical value.

Pricing & Value

Tie

Both Tool A and Tool B require direct contact for pricing, and neither provides transparent cost information in the provided data. Tool B does mention that pricing 'Varies by configuration, optional features, and regional distribution agreements,' which is typical for complex medical hardware. Without specific pricing details or cost-benefit analyses, it is impossible to determine which offers better value.

Enterprise Readiness

cV4 Diagnostic Ultrasound System

Tool B demonstrates superior enterprise readiness with explicit mentions of 'DICOM 3.0 compatibility for seamless image management' and 'Comprehensive cybersecurity: Windows 11 OS, SSD encryption (BitLocker), DICOM TLS, Audit Trails.' These features are critical for secure integration into hospital IT infrastructure, data handling, and compliance within a large healthcare system. While Tool A is HIPAA compliant and FDA cleared, it lacks the detailed IT integration and advanced security specifications provided by Tool B.

Innovation

cV4 Diagnostic Ultrasound System

Tool B showcases innovation through its 'World's first fanless design' for silent operation and extended lifespan, a significant engineering advancement for medical devices. Additionally, its 'Crystal Architectureu2122' for enhanced image quality and multiple AI-powered assists for automated tasks in diverse clinical applications demonstrate broad innovation. While Tool A's 3-in-1 multi-modal diagnostic approach is innovative, Tool B's combination of hardware innovation and diverse AI-driven workflow enhancements gives it an edge.

Support & Docs

Tie

Neither the provided structured facts nor general product information available without specific web searches offer any details regarding the level of support, documentation, training, or service agreements for either Tool A or Tool B. Therefore, it is not possible to distinguish between the two on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Cardio-TriTest	cV4 Diagnostic Ultrasound System
Product Name	Cardio-TriTest	cV4 Diagnostic Ultrasound System
Company	Cardio-Phoenix Inc.	Samsung Medison Co.
Primary Diagnostic Modality	3-in-1 diagnostic device combining ECG, PCG, and MCG	Diagnostic ultrasound system
Key AI-Powered Capabilities	AI-powered analysis for heart disease detection	AI-powered HeartAssistu2122, NerveTracku2122, BiometryAssistu2122, LaborAssistu2122
Target Specialties	Cardiology, Family Medicine, Internal Medicine	Maternal-Fetal Medicine, Obstetrics & Gynecology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Cardio-TriTest and cV4 Diagnostic Ultrasound System.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do Cardio-TriTest and the cV4 Diagnostic Ultrasound System integrate into distinct clinical workflows, and for which specific patient populations are they primarily designed?

Cardio-TriTest is designed for primary care settings, offering a non-invasive 3-in-1 diagnostic approach for earlier and more comprehensive cardiovascular disease detection. The cV4 system, conversely, is an AI-enabled ultrasound system primarily tailored for advanced imaging in Maternal-Fetal Medicine, Obstetrics & Gynecology, and Radiology, with features like automated fetal heart assessment and nerve detection.

What level of EHR integration can be expected from each device, particularly regarding the seamless management of diagnostic data and images?

The cV4 Diagnostic Ultrasound System offers DICOM 3.0 compatibility, facilitating seamless image management and integration with existing EHR systems. While Cardio-TriTest's specific EHR integration depth isn't detailed, diagnostic devices typically provide data export capabilities for incorporation into patient records.

How do the AI capabilities of each tool specifically enhance diagnostic accuracy and sensitivity within their respective clinical domains?

Cardio-TriTest utilizes AI-powered analysis to detect heart disease by synchronizing and visually correlating ECG, PCG, and MCG bio-signals for comprehensive assessment. The cV4 system employs multiple AI assists like HeartAssist for automated fetal heart assessment, NerveTrack for real-time nerve detection, BiometryAssist for automated fetal measurements, and LaborAssist for fetal angle of progression estimation, all aimed at improving diagnostic confidence and streamlining workflows.

For a healthcare organization with multiple sites or diverse specialties, how do the distinct focuses of Cardio-TriTest and the cV4 system influence their suitability for a broader rollout?

Cardio-TriTest is specialized for cardiology, family medicine, and internal medicine, making it suitable for primary care and cardiovascular screening across multiple general practice sites. The cV4 system, with its focus on maternal-fetal medicine, OB/GYN, and radiology, would be best suited for departments or sites requiring advanced ultrasound imaging capabilities in those specific specialties.

What is the anticipated learning curve for clinical staff to become proficient with each system, and how quickly can a practice expect to realize clinical value?

Cardio-TriTest, being a non-invasive 3-in-1 device for primary care, may offer a relatively straightforward learning curve for its synchronized bio-signal acquisition and visual correlation features. The cV4, as an advanced ultrasound system with multiple AI assists, might require a more extensive learning period for its imaging and specialized AI functions, though its streamlined workflows aim to accelerate diagnostic confidence and efficiency.